Neuropsychiatrie s.r.o.
- Address
- lock Available on a paid plan
Neuropsychiatrie s.r.o. - Neuropsychiatric Research Center
Neuropsychiatrie s.r.o. is a specialized clinical research facility focusing on complex neuropsychiatric and neurodegenerative conditions. The center demonstrates significant expertise in conducting advanced clinical trials for cognitive disorders and severe mental health conditions, with particular emphasis on innovative therapeutic approaches for conditions that present substantial challenges to current treatment paradigms.
- Alzheimer's disease and cognitive impairment research, including mild cognitive impairment (MCI) and mild dementia
- Schizophrenia treatment optimization and adjunctive therapy evaluation
- Novel drug development and safety assessment for neuropsychiatric disorders
The research center's portfolio reflects a commitment to addressing critical unmet medical needs in both neurodegenerative diseases and psychiatric disorders. Their investigations encompass comprehensive efficacy and safety evaluations, utilizing standardized clinical assessment tools such as the Clinical Dementia Rating-Sum of Boxes (CDR-SB) and focusing on patient populations with inadequate response to conventional treatments. This dual focus on cognitive decline and psychotic disorders positions Neuropsychiatrie s.r.o. as a versatile facility capable of conducting complex, multi-phase clinical trials in the neuropsychiatric domain.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neuropsychiatrie s.r.o.
lock Showing 1 of 15 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP) | Acadia Pharmaceuticals Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 3 | Unknown | 2025-11-18 | 2026-06-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.